IL141335A0 - Therapies for treating pulmonary diseases - Google Patents

Therapies for treating pulmonary diseases

Info

Publication number
IL141335A0
IL141335A0 IL14133599A IL14133599A IL141335A0 IL 141335 A0 IL141335 A0 IL 141335A0 IL 14133599 A IL14133599 A IL 14133599A IL 14133599 A IL14133599 A IL 14133599A IL 141335 A0 IL141335 A0 IL 141335A0
Authority
IL
Israel
Prior art keywords
therapies
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
IL14133599A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL141335A0 publication Critical patent/IL141335A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14133599A 1998-08-26 1999-08-24 Therapies for treating pulmonary diseases IL141335A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9797398P 1998-08-26 1998-08-26
PCT/US1999/019332 WO2000012078A1 (en) 1998-08-26 1999-08-24 Therapies for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
IL141335A0 true IL141335A0 (en) 2002-03-10

Family

ID=22266001

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14133599A IL141335A0 (en) 1998-08-26 1999-08-24 Therapies for treating pulmonary diseases

Country Status (21)

Country Link
US (2) US6288118B1 (enExample)
EP (1) EP1107747A4 (enExample)
JP (1) JP2002523452A (enExample)
KR (1) KR20010072931A (enExample)
CN (1) CN1314811A (enExample)
AR (1) AR022072A1 (enExample)
AU (1) AU754379B2 (enExample)
BR (1) BR9913152A (enExample)
CA (1) CA2341488A1 (enExample)
CZ (1) CZ293735B6 (enExample)
DZ (1) DZ2876A1 (enExample)
HU (1) HUP0103160A3 (enExample)
IL (1) IL141335A0 (enExample)
MA (1) MA26302A1 (enExample)
MY (1) MY126544A (enExample)
NO (1) NO20010882D0 (enExample)
NZ (1) NZ527232A (enExample)
PE (1) PE20001032A1 (enExample)
PL (1) PL346271A1 (enExample)
TR (1) TR200100500T2 (enExample)
WO (1) WO2000012078A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525018B1 (en) 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US6624181B1 (en) 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
EP1107747A4 (en) * 1998-08-26 2003-04-23 Smithkline Beecham Corp COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
HRP20020158B1 (en) * 1999-08-21 2007-08-31 Altana Pharma Ag Action of synergistic combination
NZ522882A (en) 2000-06-05 2004-07-30 Altana Pharma Bv Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
CA2462291A1 (en) * 2001-10-05 2003-04-17 The General Hospital Corporation Methods and compositions for treating dermal lesions
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
AU2002351181B2 (en) * 2001-11-28 2008-08-07 The General Hospital Corporation Methods and compositions for treating lesions of the respiratory epithelium
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003224773B2 (en) * 2002-03-26 2010-08-26 The General Hospital Corporation Combination therapy using trefoil peptides
MXPA04011018A (es) * 2002-05-07 2005-01-25 Altana Pharma Ag Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
DE10220459A1 (de) * 2002-05-07 2003-11-27 Byk Gulden Lomberg Chem Fab Neue Kombination zur Behandlung von Atemwegserkrankungen
DE10220458A1 (de) * 2002-05-07 2003-11-27 Altana Pharma Ag Kombination zur Behandlung von Atemwegserkrankungen
HRP20041159A2 (en) * 2002-05-07 2005-08-31 Altana Pharma Ag Combination for the treatment of airway disorders
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
DK1567140T3 (da) * 2002-11-27 2008-11-03 Nycomed Gmbh Synergistisk kombination der omfatter roflumilast og (R,R)-formoterol
CA2506962C (en) * 2002-11-27 2012-01-03 Altana Pharma Ag Synergistic combination comprising roflumilast and formoterol
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
WO2004087151A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
US20090035224A1 (en) * 2004-06-14 2009-02-05 Sepracor Inc. Methods of Using Albuterol and Calcium Activated Potassium Channel Openers
JP2008502699A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
US8663694B2 (en) 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
US20080254029A1 (en) * 2007-04-11 2008-10-16 Alcon Research, Ltd. Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis
KR101815716B1 (ko) * 2009-04-22 2018-01-05 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 만성 폐쇄성 폐 질환 및 천식의 치료에 사용하기 위한 조성물
CA2773483A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof
KR101035488B1 (ko) * 2009-10-05 2011-05-20 숭실대학교산학협력단 자동차 블랙박스 영상물 수집 방법
WO2011056561A1 (en) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
US8394829B2 (en) 2010-05-10 2013-03-12 Gilead Sciences, Inc. Bi-functional quinoline analogs
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US10433624B2 (en) * 2015-03-26 2019-10-08 Nike, Inc. Duffel bag
WO2019157144A1 (en) 2018-02-07 2019-08-15 Duke University System and method for homogenous gpcr phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
FR2390164A1 (fr) 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
US5602110A (en) 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis
FR2753706B1 (fr) 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2753969B1 (fr) 1996-09-27 1998-10-30 Adir Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0975347B1 (de) * 1997-02-28 2008-02-20 Nycomed GmbH Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse-agonisten
US5858694A (en) 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
EP1107747A4 (en) * 1998-08-26 2003-04-23 Smithkline Beecham Corp COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES

Also Published As

Publication number Publication date
TR200100500T2 (tr) 2001-06-21
CN1314811A (zh) 2001-09-26
EP1107747A1 (en) 2001-06-20
BR9913152A (pt) 2001-05-15
NO20010882L (no) 2001-02-21
AU754379B2 (en) 2002-11-14
PE20001032A1 (es) 2000-11-10
US6555583B2 (en) 2003-04-29
NO20010882D0 (no) 2001-02-21
HUP0103160A3 (en) 2002-11-28
JP2002523452A (ja) 2002-07-30
CZ2001692A3 (cs) 2002-02-13
NZ527232A (en) 2005-03-24
PL346271A1 (en) 2002-01-28
AU5493999A (en) 2000-03-21
MY126544A (en) 2006-10-31
CA2341488A1 (en) 2000-03-09
DZ2876A1 (fr) 2003-12-15
HUP0103160A2 (hu) 2002-01-28
EP1107747A4 (en) 2003-04-23
MA26302A1 (fr) 2004-10-01
AR022072A1 (es) 2002-09-04
KR20010072931A (ko) 2001-07-31
US20010056122A1 (en) 2001-12-27
WO2000012078A1 (en) 2000-03-09
US6288118B1 (en) 2001-09-11
CZ293735B6 (cs) 2004-07-14

Similar Documents

Publication Publication Date Title
PL346271A1 (en) Therapies for treating pulmonary diseases
NO20004688D0 (no) Terapi ved østrogenassosierte lidelser
GB9816263D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9808663D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
GB9816556D0 (en) Therapy
GB9801397D0 (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9808665D0 (en) Therapeutic compounds
EP0991411A4 (en) TREATMENT OF PULMONARY FIBROSIS
GB9824897D0 (en) Therapeutic compounds
GB9811879D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents
ZA991786B (en) Therapeutic treatment for asthma.
HK1037539A (en) Therapies for treating pulmonary diseases
GB9815317D0 (en) Therapeutic agents
GB9816723D0 (en) Therapeutic agents
GB9817838D0 (en) Therapeutic agents
GB9808667D0 (en) Therapeutic compounds
GB9806039D0 (en) Therapy
LT98209A (en) Oinment for treating skin diseases